🔎 Trials Near Me

Hem › Myelodysplastiska syndrom › Pennsylvania

Kliniska studier för Myelodysplastiska syndrom i Pennsylvania

17 studier för Myelodysplastiska syndrom söker deltagare vid platser i Pennsylvania.

Städer i Pennsylvania

Officiell studietext (engelska)

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

  • Geisinger Medical Center, Danville
  • UPMC Hillman Cancer Center, Pittsburgh
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06577441

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Geisinger Medical Center, Danville
  • Penn State Milton S Hershey Medical Center, Hershey
  • och 6 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • University of Pennsylvania, Philadelphia
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  • Thomas Jefferson University, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT07422480

Collection of Tissue Samples for Cancer Research

  • University of Pittsburgh Medical Center, Pittsburgh
RekryterarObservationsstudie
2 Months · Alla kön · Uppdaterad 16 sep. 2026 · NCT00900198

A Study of BGB-11417 in Participants With Myeloid Malignancies

  • Upmc Hillman Cancer Center(Univ of Pittsburgh), Pittsburgh
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT04771130

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

  • UPENN Perelman Center for Advanced Medicine, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT06846606

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Geisinger Medical Center, Danville
  • Penn State Children's Hospital, Hershey
  • och 3 fler
RekryterarFas 1/2
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

  • UMPC Hillman Cancer Center, Pittsburgh
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT07565220

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

  • UPMC Hillman Cancer Center, Pittsburgh
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 11 aug. 2026 · NCT06529731

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

  • Children's Hospital of Philadelphia, Philadelphia
Rekryterar
Upp till ålder 25 · Alla kön · Uppdaterad 8 juli 2026 · NCT03810196

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  • Sidney Kimmel Comprehensive Cancer Center, Philadelphia
  • Allegheny Health Network, Pittsburgh
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 24 mars 2026 · NCT04988555

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
RekryterarFas 2
Ålder 1 till 60 · Alla kön · Uppdaterad 12 mars 2026 · NCT03970096

Home Blood Transfusions

  • Thomas Jefferson University Hospital, Philadelphia
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 16 dec. 2025 · NCT07121140

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

  • Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 2
Ålder 10 till 30 · Alla kön · Uppdaterad 4 dec. 2025 · NCT05194397

Two Step Haplo With Radiation Conditioning

  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadephia
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 30 okt. 2025 · NCT05031897

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Philadelphia
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.